Cybin Inc. Raises $25.2M in Public Offering
Ticker: HELP · Form: 6-K · Filed: Sep 20, 2024 · CIK: 1833141
| Field | Detail |
|---|---|
| Company | Cybin INC. (HELP) |
| Form Type | 6-K |
| Filed Date | Sep 20, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | bullish |
Sentiment: bullish
Topics: financing, public-offering, clinical-trials, biotech
TL;DR
Cybin closed a $25.2M offering to fund R&D and clinical trials for its psychedelic treatments.
AI Summary
On September 19, 2024, Cybin Inc. announced the closing of its previously announced bought-deal public offering, raising gross proceeds of approximately CAD $34.5 million (USD $25.2 million). The offering involved the sale of 34,500,000 units at a price of CAD $1.00 per unit. The net proceeds will be used for research and development, clinical trials, and general corporate purposes.
Why It Matters
This capital infusion strengthens Cybin's financial position, enabling continued progress in its clinical trials for psychedelic-based therapeutics, potentially impacting the future of mental health treatment.
Risk Assessment
Risk Level: medium — The company operates in the highly regulated and speculative field of psychedelic therapeutics, with significant clinical trial risks and market uncertainties.
Key Numbers
- CAD $34.5M — Gross Proceeds (Raised from the public offering to fund operations and development.)
- USD $25.2M — Gross Proceeds (USD) (Equivalent amount raised in US dollars.)
- 34,500,000 — Units Sold (Number of units sold in the public offering.)
- CAD $1.00 — Price Per Unit (The price at which each unit was offered.)
Key Players & Entities
- Cybin Inc. (company) — Registrant and issuer of the offering
- Doug Drysdale (person) — Chief Executive Officer of Cybin Inc.
- CAD $34.5 million (dollar_amount) — Gross proceeds from the public offering
- USD $25.2 million (dollar_amount) — Approximate equivalent of gross proceeds in USD
- September 19, 2024 (date) — Date of the news release announcing the offering closing
- September 20, 2024 (date) — Filing date of the 6-K report
FAQ
What was the total amount of gross proceeds raised by Cybin Inc. in its recent public offering?
Cybin Inc. raised gross proceeds of approximately CAD $34.5 million (USD $25.2 million).
On what date did Cybin Inc. announce the closing of its public offering?
The closing of the public offering was announced in a news release dated September 19, 2024.
What is the intended use of the net proceeds from the offering?
The net proceeds are intended to be used for research and development, clinical trials, and general corporate purposes.
What was the price per unit for the shares offered in the public offering?
The units were offered at a price of CAD $1.00 per unit.
Who signed the 6-K report on behalf of Cybin Inc.?
The 6-K report was signed by Doug Drysdale, Chief Executive Officer of Cybin Inc.
Filing Stats: 147 words · 1 min read · ~1 pages · Grade level 10.6 · Accepted 2024-09-20 13:04:17
Filing Documents
- cybininc-form6xk09x19x2024.htm (6-K) — 11KB
- a09-19x2024cybincorporateu.htm (EX-99.1) — 28KB
- image_0a.jpg (GRAPHIC) — 25KB
- 0001628280-24-041003.txt ( ) — 74KB
From the Filing
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September, 2024. Commission File Number 001-40673 Cybin Inc. (Exact Name of Registrant as Specified in Charter) 100 King Street West, Suite 5600, Toronto, Ontario, M5X 1C9 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CYBIN INC. (Registrant) Date September 20, 2024 By s Doug Drysdale Name Doug Drysdale Title Chief Executive Officer EXHIBIT INDEX 99.1 News Release dated September 19, 2024